SUJA LIFE, INC. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring between May 6, 2026, and May 8, 2026. Suja Life, Inc. (the "Company"), a Delaware corporation, reports the consummation of its Initial Public Offering (IPO) and related corporate reorganization activities. The Company is listed on The Nasdaq Stock Market LLC under the trading symbol "SUJA."
Key Financial Metrics and Transaction Details
The filing details the financial terms of the IPO rather than historical operating results:
- Offering Size: 8,888,889 shares of Class A Common Stock (Firm Shares).
- Offering Price: $21.00 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 1,333,333 additional shares.
- Closing Date: The IPO closed on May 8, 2026.
- Unregistered Issuance: 14,836,312 shares of Class V Common Stock were issued to LP Unitholders in connection with the IPO.
- Debt Facilities: A Fifth Amendment to the Credit Agreement was executed on May 8, 2026, to facilitate the IPO reorganization. Specific debt balances or liquidity figures are not provided in this filing.
Material Changes Versus Prior Period
This filing represents a material change in the Company's capital structure and corporate status:
- Public Status: Transition from a private entity to a publicly traded company on Nasdaq.
- Capital Structure: Introduction of Class A Common Stock and Class V Common Stock.
- Corporate Governance: Adoption of an Amended and Restated Certificate of Incorporation and Bylaws effective May 7, 2026.
- Board Composition: Appointment of six new directors: Alex Corbacho, Robert DeBorde, Randy Papadellis, Mark Partin, Kevin Schwartz, and Kathy Vrabeck.
Guidance, Outlook, and Material Agreements
The filing does not contain forward-looking financial guidance or management commentary on future performance. However, it discloses several material agreements entered into in connection with the IPO:
- Underwriting Agreement: Entered with Goldman Sachs & Co. LLC, Jefferies LLC, and William Blair & Company, L.L.C.
- Tax Receivable Agreement (TRA): Executed on May 7, 2026, regarding tax benefits.
- Exchange Agreement: Executed on May 7, 2026, governing the exchange of interests.
- Director Designation Agreement: Defines board representation rights.
- Compensation Plans: Adoption of the 2026 Omnibus Incentive Plan and execution of indemnification agreements for directors and officers.
Investor Verification Checklist
- Verify the final number of shares sold, including any exercise of the 1,333,333 share over-allotment option.
- Review the full text of the Tax Receivable Agreement (Exhibit 10.3) to understand potential future cash outflows related to tax benefits.
- Examine the Prospectus (filed May 8, 2026) for detailed risk factors and use of proceeds.
- Confirm the specific terms of the Fifth Amendment to the Credit Agreement (Exhibit 10.5) regarding debt covenants and interest rates.
- Review the "Description of Capital Stock" in the Prospectus to understand the voting rights and preferences of the Class V Common Stock.